Cancer


Mays Cancer Center conducting study to learn how COVID-19 vaccine affects patients with cancer

March 4, 2021

Individuals with cancer who get COVID-19 are more likely to have severe illness and higher death rates compared to the general public. This study aims to help prevent worse outcomes in patients with cancer and COVID-19




Bladder cancer is more advanced in South Texas, study finds

March 4, 2021

Bladder cancer is more aggressive and more advanced in South Texas residents ­than in many parts of the country, a study by the Mays Cancer Center indicates.




$6 million CPRIT award to bring veteran cancer researcher

March 2, 2021

UT Health San Antonio and its Mays Cancer Center will receive a $6 million award from the Cancer Prevention and Research Institute of Texas to recruit Alexander Mazin, PhD, a senior, highly accomplished biochemist and cancer biologist currently at Drexel University College of Medicine.



DocWire News.com: Bladder cancer is more deadly in South Texas, and among latinos and women, study finds

March 2, 2021

This DocWire News story is about a study by the Mays Cancer Center, home to UT Health San Antonio MD Anderson, that indicates that bladder cancer is more aggressive and more advanced in South Texas residents ­than in many parts of the country. Read the story.


KSAT 12: KSAT Community spotlight: SA Cancer Council

March 2, 2021

This KSAT Community spotlight is about the SA Cancer Council, an all-volunteer nonprofit organization with a mission to support the Mays Cancer Center. Watch the story. 


San Antonio Express-News: UT Health San Antonio gets $6 million grant for DNA cancer research from state agency

March 1, 2021

By Laura Garcia, Staff writer, published on Feb. 26, 2021 UT Health San Antonio has received a $6 million academic research grant from a state-funded program that invests billions in cancer-fighting efforts. The major grant from the Cancer Prevention and Research Institute of Texas or CPRIT swayed Alexander Mazin, a senior biochemist and cancer biologist […]